• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酮酸脱氢酶激酶 3 的过表达增加了结肠癌的耐药性和早期复发。

Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer.

机构信息

Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

出版信息

Am J Pathol. 2011 Sep;179(3):1405-14. doi: 10.1016/j.ajpath.2011.05.050. Epub 2011 Jul 18.

DOI:10.1016/j.ajpath.2011.05.050
PMID:21763680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3157210/
Abstract

The switch of cellular metabolism from mitochondrial respiration to glycolysis is the hallmark of cancer cells and is associated with tumor malignancy. Pyruvate dehydrogenase kinase-1 (PDK1) and PDK3 participate in the metabolic switch of cancer cells; however, the medical significance of PDK1 and PDK3 in cancer progression is not known. Here, we assessed the expression profiles of PDK1 and PDK3 in colorectal cancer. Western blot analysis (n = 74) demonstrated that PDK3 was markedly increased in colon cancer compared to that in adjacent normal tissues, whereas PDK1 was decreased in cancer cells. In addition, PDK3 expression was positively correlated with that of hypoxia inducible factor-1α (HIF-1α) in cancer cells. Further analysis using immunohistochemical staining revealed that PDK3 levels were positively associated with severity of cancer and negatively associated with disease-free survival. In vitro studies using several colon cancer cell lines showed that PDK3 expression was controlled by HIF-1α and contributed to hypoxia-induced increased drug resistance, perhaps explaining why patients with PDK3 overexpression have a greater incidence of treatment failure. Taken together, our findings suggest that PDK3 plays an important role in the metabolic switch and drug resistance of colon cancer and is potentially a novel target for cancer therapy.

摘要

细胞代谢从线粒体呼吸向糖酵解的转变是癌细胞的标志,与肿瘤恶性程度相关。丙酮酸脱氢酶激酶-1(PDK1)和 PDK3 参与癌细胞的代谢转换;然而,PDK1 和 PDK3 在癌症进展中的医学意义尚不清楚。在这里,我们评估了 PDK1 和 PDK3 在结直肠癌中的表达谱。Western blot 分析(n = 74)表明,与相邻正常组织相比,PDK3 在结肠癌中明显增加,而 PDK1 在癌细胞中减少。此外,PDK3 的表达与癌细胞中缺氧诱导因子-1α(HIF-1α)的表达呈正相关。使用免疫组织化学染色的进一步分析表明,PDK3 水平与癌症的严重程度呈正相关,与无病生存率呈负相关。使用几种结肠癌细胞系进行的体外研究表明,PDK3 的表达受 HIF-1α 控制,并有助于缺氧诱导的耐药性增加,这也许可以解释为什么 PDK3 过表达的患者更易发生治疗失败。综上所述,我们的研究结果表明,PDK3 在结肠癌的代谢转换和耐药性中发挥重要作用,可能是癌症治疗的一个新靶点。

相似文献

1
Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer.丙酮酸脱氢酶激酶 3 的过表达增加了结肠癌的耐药性和早期复发。
Am J Pathol. 2011 Sep;179(3):1405-14. doi: 10.1016/j.ajpath.2011.05.050. Epub 2011 Jul 18.
2
Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance.缺氧诱导因子-1诱导丙酮酸脱氢酶激酶-3可促进代谢转换和耐药性。
J Biol Chem. 2008 Oct 17;283(42):28106-14. doi: 10.1074/jbc.M803508200. Epub 2008 Aug 21.
3
HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.HIF1α 通过早期糖酵解转变和 PDK1-3 和 PKM2 的上调来调节细胞命运重编程。
Stem Cells. 2014 Feb;32(2):364-76. doi: 10.1002/stem.1552.
4
Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.抑制 HIF-1α/PDK3 信号轴促使黑色素瘤向线粒体氧化代谢转化,并增强促氧化剂的治疗活性。
Cancer Res. 2012 Oct 1;72(19):5035-47. doi: 10.1158/0008-5472.CAN-12-0979. Epub 2012 Aug 3.
5
Diversity of the pyruvate dehydrogenase kinase gene family in humans.人类丙酮酸脱氢酶激酶基因家族的多样性
J Biol Chem. 1995 Dec 1;270(48):28989-94. doi: 10.1074/jbc.270.48.28989.
6
Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.糖酵解守门员 PDK1 在低氧条件下重编程乳腺癌干细胞。
Oncogene. 2018 Feb 22;37(8):1062-1074. doi: 10.1038/onc.2017.368. Epub 2017 Nov 6.
7
Inhibition of the ubiquitin-proteasome system reduces the abundance of pyruvate dehydrogenase kinase 1 in cultured myotubes.抑制泛素-蛋白酶体系统可减少培养的肌管中丙酮酸脱氢酶激酶 1 的含量。
J Muscle Res Cell Motil. 2024 Sep;45(3):155-169. doi: 10.1007/s10974-024-09679-3. Epub 2024 Jul 31.
8
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic mutant colon cancer.在缺氧的突变型结肠癌中,维生素C通过作用于线粒体三羧酸(TCA)循环来激活丙酮酸脱氢酶(PDH)。
Theranostics. 2021 Jan 25;11(8):3595-3606. doi: 10.7150/thno.51265. eCollection 2021.
9
Pyruvate dehydrogenase kinase 1 is essential for transplantable mouse bone marrow hematopoietic stem cell and progenitor function.丙酮酸脱氢酶激酶1对可移植的小鼠骨髓造血干细胞和祖细胞功能至关重要。
PLoS One. 2017 Feb 9;12(2):e0171714. doi: 10.1371/journal.pone.0171714. eCollection 2017.
10
Metabolic enzyme PDK3 forms a positive feedback loop with transcription factor HSF1 to drive chemoresistance.代谢酶 PDK3 与转录因子 HSF1 形成正反馈回路,从而驱动化学抗性。
Theranostics. 2019 May 9;9(10):2999-3013. doi: 10.7150/thno.31301. eCollection 2019.

引用本文的文献

1
PDK4 expression and tumor aggressiveness in prostate cancer.前列腺癌中PDK4的表达与肿瘤侵袭性
Investig Clin Urol. 2025 May;66(3):227-235. doi: 10.4111/icu.20240434.
2
Resistance to Radiotherapy in Cancer.癌症对放疗的抗性
Diseases. 2025 Jan 17;13(1):22. doi: 10.3390/diseases13010022.
3
Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer.克服头颈癌对放化疗的内在和获得性耐药的策略
Cells. 2024 Dec 27;14(1):18. doi: 10.3390/cells14010018.
4
Exploring PDK3 inhibition in lung cancer through drug repurposing for potential therapeutic interventions.通过药物再利用探索肺癌中的 PDK3 抑制作用,以寻找潜在的治疗干预措施。
Sci Rep. 2024 Nov 29;14(1):29672. doi: 10.1038/s41598-024-78022-0.
5
Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents.新型二氯乙酰苯酮类 PDHK1 抑制剂作为有效的抗癌药物。
Drug Des Devel Ther. 2024 Oct 18;18:4661-4679. doi: 10.2147/DDDT.S473437. eCollection 2024.
6
p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect.p53 调控癌症代谢:揭示逆转瓦博格效应的策略。
Bull Math Biol. 2024 Aug 29;86(10):124. doi: 10.1007/s11538-024-01346-5.
7
Investigating Pyruvate Dehydrogenase Kinase 3 Inhibitory Potential of Myricetin Using Integrated Computational and Spectroscopic Approaches.运用综合计算和光谱学方法研究杨梅素对丙酮酸脱氢酶激酶3的抑制潜力
ACS Omega. 2024 Jun 26;9(27):29633-29643. doi: 10.1021/acsomega.4c03001. eCollection 2024 Jul 9.
8
PDK3 drives colorectal carcinogenesis and immune evasion and is a therapeutic target for boosting immunotherapy.丙酮酸脱氢酶激酶3(PDK3)驱动结直肠癌发生及免疫逃逸,是增强免疫治疗的一个治疗靶点。
Am J Cancer Res. 2024 Jun 15;14(6):3117-3129. doi: 10.62347/QWKZ3078. eCollection 2024.
9
Drug resistance mechanisms in cancers: Execution of pro-survival strategies.癌症中的耐药机制:促生存策略的实施
J Biomed Res. 2024 Feb 28;38(2):95-121. doi: 10.7555/JBR.37.20230248.
10
Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer.miR-379/miR-656(C14MC)簇在宫颈癌中的调控和肿瘤抑制功能。
Mol Oncol. 2024 Jun;18(6):1608-1630. doi: 10.1002/1878-0261.13611. Epub 2024 Feb 23.

本文引用的文献

1
Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops.磷酸化导致人丙酮酸脱氢酶复合体失活的结构基础:无序磷酸化环的作用
Structure. 2008 Dec 10;16(12):1849-59. doi: 10.1016/j.str.2008.10.010.
2
Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer.缺氧对CD151的调控作用控制结直肠癌中的细胞黏附和转移。
Clin Cancer Res. 2008 Dec 15;14(24):8043-51. doi: 10.1158/1078-0432.CCR-08-1651. Epub 2008 Dec 10.
3
Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance.缺氧诱导因子-1诱导丙酮酸脱氢酶激酶-3可促进代谢转换和耐药性。
J Biol Chem. 2008 Oct 17;283(42):28106-14. doi: 10.1074/jbc.M803508200. Epub 2008 Aug 21.
4
PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer.丙酮酸脱氢酶激酶1(PDK-1)在缺氧状态下调节乳酸生成,且与头颈部鳞状细胞癌的不良预后相关。
Br J Cancer. 2008 Jun 17;98(12):1975-84. doi: 10.1038/sj.bjc.6604356. Epub 2008 Jun 10.
5
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells.丙酮酸脱氢酶复合体活性控制癌细胞的代谢和恶性表型。
J Biol Chem. 2008 Aug 15;283(33):22700-8. doi: 10.1074/jbc.M801765200. Epub 2008 Jun 9.
6
Systemic treatment of colorectal cancer.结直肠癌的全身治疗
Gastroenterology. 2008 May;134(5):1296-310. doi: 10.1053/j.gastro.2008.02.098.
7
Cellular life span and the Warburg effect.细胞寿命与瓦伯格效应。
Exp Cell Res. 2008 Jun 10;314(9):1923-8. doi: 10.1016/j.yexcr.2008.03.007. Epub 2008 Mar 20.
8
Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer.丙酮酸脱氢酶激酶的调节机制及其在治疗糖尿病、心脏缺血和癌症中的抑制作用。
Cell Mol Life Sci. 2007 Apr;64(7-8):830-49. doi: 10.1007/s00018-007-6380-z.
9
Prostaglandin E2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling.前列腺素E2通过依赖EP3的蛋白激酶Cδ和Elk-1信号传导诱导成纤维细胞生长因子9。
Mol Cell Biol. 2006 Nov;26(22):8281-92. doi: 10.1128/MCB.00941-06. Epub 2006 Sep 18.
10
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.缺氧诱导因子-1通过积极下调线粒体氧消耗来介导对缺氧的适应。
Cell Metab. 2006 Mar;3(3):187-97. doi: 10.1016/j.cmet.2006.01.012.